Regions in Ebola Virus VP24 That Are Important for Nucleocapsid Formation

Takeshi Noda; Halfmann, Peter; Hiroshi Sagara; Yoshihiro Kawaoka
November 2007
Journal of Infectious Diseases;11/15/2007 Supplement, Vol. 196 Issue 2, pS247
Academic Journal
Ebola virus (EBOV) VP24, together with nucleoprotein and VP35, is an essential component of viral RNA-protein complexes called "nucleocapsids." In this study, using a series of deletion mutants of VP24, we identified regions within VP24 that are important for the formation of nucleocapsid-like structures and determined that both termini of VP24 are essential for nucleocapsid formation. This finding advances our knowledge of both EBOV morphogenesis and the nature of VP24 molecules in nucleocapsid formation, which will be useful for the development of antiviral compounds.


Related Articles

  • Clinical trials of Ebola therapies to begin this year in Guinea. Gulland, Anne // BMJ: British Medical Journal;11/22/2014, Vol. 349 Issue 7894, pg6827 

    The article reports that the first clinical trials of therapies for Ebola virus disease will start in December 2015 in the treatment areas run by Humanitarian aid organization Médecins Sans Frontières in Guinea, with investigators testing the antiviral drugs favipiravir and brincidofovir.

  • The Ebola Virus Glycoprotein and HIV-1 Vpu Employ Different Strategies to Counteract the Antiviral Factor Tetherin. Kühl, Annika; Banning, Carina; Marzi, Andrea; Votteler, Jörg; Steffen, Imke; Bertram, Stephanie; Glowacka, Ilona; Konrad, Andreas; Stürzl, Michael; Guo, Ju-Tao; Schubert, Ulrich; Feldmann, Heinz; Behrens, Georg; Schindler, Michael; Pöhlmann1, Stefan // Journal of Infectious Diseases;2011 Supplement 3, Vol. 204, pS850 

    The antiviral protein tetherin/BST2/CD317/HM1.24 restricts cellular egress of human immunodeficiency virus (HIV) and of particles mimicking the Ebola virus (EBOV), a hemorrhagic fever virus. The HIV-1 viral protein U (Vpu) and the EBOV-glycoprotein (EBOV-GP) both inhibit tetherin. Here, we...

  • Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents. Kiselev, O.; Vasin, A.; Shevyryova, M.; Deeva, E.; Sivak, K.; Egorov, V.; Tsvetkov, V.; Egorov, A.; Romanovskaya-Romanko, E.; Stepanova, L.; Komissarov, A.; Tsybalova, L.; Ignatjev, G. // Molecular Biology;Jul2015, Vol. 49 Issue 4, p480 

    Ebola hemorrhagic fever (EHF) epidemic currently ongoing in West Africa is not the first among numerous epidemics in the continent. Yet it seems to be the worst EHF epidemic outbreak caused by Ebola virus Zaire since 1976 as regards its extremely large scale and rapid spread in the population....

  • Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism. Burgt, Nathan H. Vande; Kaletsky, Rachel L.; Bates, Paul // Viruses (1999-4915);2015, Vol. 7 Issue 10, p5587 

    Tetherin is an interferon-induced, intrinsic cellular response factor that blocks release of numerous viruses, including Ebola virus, from infected cells. As with many viruses targeted by host factors, Ebola virus employs a tetherin antagonist, the viral glycoprotein (EboGP), to counteract...

  • Molecular Determinants of Ebola Virus Virulence in Mice. Ebihara, Hideki; Takada, Ayato; Kobasa, Darwyn; Jones, Steven; Neumann, Gabriele; Theriault, Steven; Bray, Mike; Feldmann, Heinz; Kawaoka, Yoshihiro // PLoS Pathogens;Jul2006, Vol. 2 Issue 7, pe73 

    Zaire ebolavirus (ZEBOV) causes severe hemorrhagic fever in humans and nonhuman primates, with fatality rates in humans of up to 90%. The molecular basis for the extreme virulence of ZEBOV remains elusive. While adult mice resist ZEBOV infection, the Mayinga strain of the virus has been...

  • FAM134B, the Selective Autophagy Receptor for Endoplasmic Reticulum Turnover, Inhibits Replication of Ebola Virus Strains Makona and Mayinga. Chiramel, Abhilash I.; Dougherty, Jonathan D.; Nair, Vinod; Robertson, Shelly J.; Best, Sonja M. // Journal of Infectious Diseases;2016 Supplement, Vol. 214, pS319 

    Selective autophagy of the endoplasmic reticulum (termed ER-phagy) is controlled by members of the FAM134 reticulon protein family. Here we used mouse embryonic fibroblasts from mice deficient in FAM134B to examine the role of the ER in replication of historic (Mayinga) or contemporary (Makona...

  • Nature: Researchers identify protein essential in transmission of Ebola virus.  // Biomedical Market Newsletter;9/12/2011, Vol. 21, p300 

    The article presents the study conducted by researchers from Brigham and Women's Hospital which identifies essential protein in the transmission of Ebola virus in New England.

  • Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Côté, Marceline; Misasi, John; Ren, Tao; Bruchez, Anna; Lee, Kyungae; Filone, Claire Marie; Hensley, Lisa; Li, Qi; Ory, Daniel; Chandran, Kartik; Cunningham, James // Nature;9/15/2011, Vol. 477 Issue 7364, p344 

    Ebola virus (EboV) is a highly pathogenic enveloped virus that causes outbreaks of zoonotic infection in Africa. The clinical symptoms are manifestations of the massive production of pro-inflammatory cytokines in response to infection and in many outbreaks, mortality exceeds 75%. The...

  • Identification of Continuous Human B-Cell Epitopes in the VP35, VP40, Nucleoprotein and Glycoprotein of Ebola Virus. Becquart, Pierre; Mahlakõiv, Tanel; Nkoghe, Dieudonné; Leroy, Eric M. // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    Ebola virus (EBOV) is a highly virulent human pathogen. Recovery of infected patients is associated with efficient EBOV-specific immunoglobulin G (IgG) responses, whereas fatal outcome is associated with defective humoral immunity. As B-cell epitopes on EBOV are poorly defined, we sought to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics